Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Multiple Myeloma 1Leukemia, Plasma Cell 1Esophageal Neoplasms 1Barrett Esophagus 1Atypical Squamous Cells of the Cervix 1Adenocarcinoma Of Esophagus 1

Interventions

Whole-Body Irradiation 6Peripheral Blood Stem Cell Transplantation 6Biopsy 6fludarabine phosphate 5Immunohistochemistry 5Epoetin Alfa 5Cyclophosphamide 5Tacrolimus 4Methotrexate 4Gene Expression Profiling 4Celecoxib 4Mycophenolic Acid 3Microarray Analysis 3Imiquimod 3Etoposide 3Darbepoetin alfa 3Cyclosporine 3Colposcopy 3Busulfan 3Antilymphocyte Serum 3Aminolevulinic Acid 3Tomography, Optical Coherence 2Sirolimus 2Polymerase Chain Reaction 2Methylprednisolone 2Melphalan 2Mass Spectrometry 2Immunoenzyme Techniques 2Filgrastim 2Fatty Acids, Omega-3 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Precancerous Conditions × High-Throughput Screening Assays × Clear all
NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡